News

Joint webinar with FIP ‘The role of pharmacists in the fight against cancer: A people-centred approach to cancer care’ https://www.fip.org/events

Find your next recruit at the International Society of Oncology Pharmacy Practitioners (ISOPP) and Canadian Association of Pharmacy in Oncology (CAPhO) 2025 Symposium. The Symposium takes place in Victoria, British Columbia from April 3 to 6 and will feature a Recruitment Fair from Thursday evening on April 3 to Saturday afternoon on April 5.

The most recent meeting of the ISOPP Global Oncology Pharmacy Leaders took place on January 16, 2025. The group has been meeting on a quarterly basis for two years now, and it has been a wonderful collaboration to support the collective advancement of oncology pharmacy practice and cancer patient care globally. The group now encompasses over 45 national organizations across the globe and continues to grow.

Read the presidents message and access the full newsletter.

The Understanding Targeted Therapies and Immunotherapies for Cancer (UTIC) course from the International Society of Oncology Pharmacy Practitioners (ISOPP) and the British Oncology Pharmacy Association (BOPA) has been awarded the FIP Seal!

As pharmacists and pharmacy technicians, we witness firsthand the profound impact a cancer diagnosis has on our patients’ lives. From physical challenges to emotional upheaval, their journey can feel overwhelming. But we’re here to support them every step of the way. This #WorldCancerDay, let’s stand united to show our patients that even when their world feels flipped, they are never alone.

The Japan Clinical Oncology and Pharmacology Society (JASPO) has translated the ISOPP Standards of Practice from English to Japanese, expanding its reach to over 5,000 oncology pharmacy practitioners in Japan.

ISOPP identified that, around the world, the role of the pharmacist in managing immunotherapy varies significantly. ISOPP has a role in supporting pharmacists through provision of education, guidance and resources. To that end, ISOPP created an Immunotherapy Task Force, whose objectives are to develop an ISOPP position statement on the pharmacist's role in the era of immunotherapy, provide education, provide advice on implementation issues in clinical practice and deliver enhanced professional development resources on immunotherapy. The Task Force has 19 members representing 12 different countries from around the world.